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Background. In a prior study the 21-aminosteroid (lazaroid)
U74389F provided in vivo protection from oxidative stress when
used as a preventive therapy in ischemia-reperfusion injury in the
kidney. As the cell membrane is the principal site for lipoperoxi-
dation, in the current study the very lipophilic 2-methylamin-
ochroman U83836E, a recently developed lazaroid, was adminis-
tered to rats at 3 mg/kg before renal ischemia-reperfusion. In
addition to the biochemical parameters, the renal function and
the histological appearance were carefully evaluated.
Methods. Glutathione, adenine nucleotides and lipid peroxida-
tion products were determined in kidneys reperfused for 2 and 24
hours after 90 minutes of ischemia. Renal function was assessed
by plasma creatinine, and renal injury by histological examination.
Results. Reperfusion-induced glutathione oxidation, expressed
as an oxidized-to-total glutathione ratio, was significantly attenu-
ated both after 2 and 24 hours of reperfusion by treatment with
U83836E. Adenosine triphosphate (ATP) was still significantly
depleted after 24 hours in the control group, while at the same
time treated animals had already recovered to baseline values.
Lipid peroxidation products were significantly lower in lazaroid-
groups both after 2 and 24 hours of reperfusion. Renal function
after 24 hours of reperfusion was notably better in the treated rats.
Histological examination confirmed the protective action of the
drug. After 24 hours the control group showed large areas of
parenchymal hemorrhage and necrosis with dilated tubules and
blood vessel thrombosis, while treated animals showed small
necrotic areas with a background of mild interstitial inflammatory
cells.
Conclusions. Our results suggest that there is a protective effect
of U83836E in ischemia-reperfusion injury, in that tissue damage
due to oxidative stress is reduced, thus ameliorating renal function
impairment.
The 21-aminosteroids, known as “lazaroids,” are drugs
developed during the past decade initially for the treatment
of central nervous system trauma, ischemia and subarach-
noid hemorrhage [1–4]. Later experimental studies showed
the efficacy of some of these compounds in the manage-
ment of cardiopulmonary arrest [5], skeletal muscle [6],
liver [7], and renal ischemia-reperfusion injury [8–10].
Several mechanisms have been proposed to explain the
protective effects of lazaroids. They can inhibit lipid per-
oxidation by interacting with ferrous ions, thus blocking
iron-mediated reactions, or act like vitamin E by scavenging
peroxyl radicals [3, 11]. Moreover, they likely present
membrane stabilizing properties and tend to inhibit the
release of free arachidonic acid from injured cells [1]. More
recently, a second generation of lazaroids has been intro-
duced. These compounds, named 2-methylaminochromans,
are based on a non-steroidal structure combining amino
functionality of the 21-aminosteroids with the tetramethyl-
chroman ring portion of a-tochopherol. The antioxidant
potency of these new compounds has been shown to be
more than tenfold that of the first generation lazaroids [12].
In particular, U78517F and its enantiomer U83836E have
been successfully employed as antioxidants in models of
focal and global cerebral ischemia [13], in cerebrovascular
spasm [14], acute lung injury [15] and in treatment of
diabetes complications [16]. Experimental evidence indi-
cating that U83836E improves survival of embryonic mes-
encephalic neurones and U78517F inhibits oxidant-stimu-
lated calcium influx have been reported [17, 18].
In 1995 we observed that administration of the 21-
aminosteroid U74389F to rats before renal ischemia and
reperfusion sensibly reduces oxidative stress and lipid per-
oxidation [10]. To have a more comprehensive view of the
physiological protection offered by lazaroids against isch-
emic injury in acute renal failure, in this study we tested the
effects of the antioxidant 2-methylaminochroman U83836E
on renal function (assessed by serum creatinine) and on
histological appearance. Moreover, as in our previous
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investigation, we carefully evaluated the biochemical status
of the cells expressed by the disturbance of prooxidant/
antioxidant balance associated to alterations in the re-
duced-to-oxidized glutathione ratio, the oxidative stress-
induced lipid peroxidation, and the high energy nucleotide
content.
METHODS
Drug
U83836E ((-)-2-[ [4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl]-
1-piperazinyl]methyl]-3,4-dihydro-2,5,7,8-tetramethyl-2H-
1-benzopyran-6-ol, dihydrochloride) (Upjohn Company,
Kalamazoo, MI, USA) was dissolved in citrate buffer pH
3.0 at a concentration of 0.75 mg/ml the day before the
study and stored at 4°C until use. Drug (3 mg/kg) or vehicle
(citrate buffer pH 3.0) were administered five minutes
before ischemia by injection into the tail vein.
Experimental protocol
Male Wistar rats (Charles River, Calco, Italy), weighing
200 to 220 g, were randomly divided into groups to receive
vehicle (groups 1 and 3) or U83836E (groups 2 and 4).
Groups 1 (N 5 8) and 2 (N 5 8) underwent 90 minutes of
ischemia plus two hours of reperfusion, and in groups 3
(N 5 6) and 4 (N 5 6) the reperfusion period was extended
to 24 hours. The animals were anesthetized with thiopen-
tone (40 mg/kg body wt, i.p.; Farmitalia, Milan, Italy) and
kidneys made ischemic for 90 minutes by occluding the left
and right renal vessels as described elsewhere [10]. Reper-
fusion was allowed for 2 or 24 hours before kidney removal.
Sham operated controls at 2 and 24 hours were also
included in the protocol. During the operation (ischemia-
reperfusion), all rats were kept on a surgical table under a
heating lamp in order to avoid dramatic changes of body
temperature. During the 24 hour reperfusion, rats were
allocated to individual cages and had free access to food
and water. After excision kidneys were rapidly divided
lengthways into two parts: one was immediately frozen in
liquid nitrogen for biochemical assays and the other was
10% formalin fixed and paraffin embedded for histological
examination. Blood samples were drawn before sacrifice in
a heparinized syringe and, after centrifugation in heparin-
ized tubes, plasma was used for creatinine determination.
Assays
Just prior to analysis frozen kidney tissue was rapidly
weighed and homogenized in cold 3.5% perchloric acid (2.5
ml), or in PBS pH 7.4 (4.5 ml) with an Ultraturrax®
homogenizer (Janke and Kunkel, GmbH and Co., Staufen,
Germany). Before homogenization, a small portion of
kidney was excised, weighed and lyophilized for the deter-
mination of dry weight.
After centrifugation (10,000 3 g at 4°C, 1 min) of the
acidic homogenate, total and oxidized soluble glutathione
were determined by a reversed-phase high pressure liquid
chromatography (HPLC) method, as described by Paroni
et al [19]. Adenine nucleotides were measured by HPLC
after neutralization of acid supernatant with sodium bicar-
bonate [10]. Lipid peroxidation was assessed by determina-
tion of diene conjugates and Schiff bases formation accord-
ing to the method of Green et al [20], slightly modified [10].
Glutathione disulphide was always expressed as glutathione
equivalents throughout the text. All data are expressed on
a per gram dry weight basis. Plasma creatinine was deter-
mined by the Jaffe` method without deproteinization and
blood urea nitrogen (BUN) by the enzymatic-colorimetric
method of Berthelot (Boehringer Mannheim Italy, Milan,
Italy).
Histological analysis
For conventional histological analysis one section, 5 mm
thickness, was cut from each paraffin block and hematox-
ylin-eosin stained. Histological assessment was semiquan-
titatively performed according to a previously published
guideline [21]. Renal morphological changes were graded
on a 0 to 3 scale in relation to the extent of kidney
alterations: 0 5 none; 1 5 up to 20%; 2 5 from 20 to 50%;
3 5 more than 50%. Seven morphologic changes were
assessed: (1) neutrophil accumulation in the vasa recta, (2)
tubular necrosis (that is, the presence of necrotic cells,
apparently denuded areas of tubular basement membranes,
or ruptured tubular basement membranes), (3) tubular
regeneration, (4) tubular cell mitoses, (5) interstitial in-
flammation, (6) tubular casts, and (7) loss of PAS-positive
brush border. Blind analysis was performed on all samples.
Statistical analysis
All data are expressed as mean 6 SE of the mean. Data
were analyzed by two-way analysis of variance (ANOVA)
followed by the Student-Newman-Keuls test as the post-
hoc test. Creatinine and BUN were analyzed by the Dun-
can’s multiple test. Concerning histological examination,
differences between groups were evaluated using the
Mann-Whitney rank sum test. Probabilities # 0.05 were
considered to be statistically significant. All analyses were
performed using the Sigma Stat (Statistical Analysis Sys-
tem, version 1.01) statistical software package (Jandel
Scientific GmbH, Erkrath, Germany) on an IBM computer.
RESULTS
No animal died during this study. Sham-operated ani-
mals at 0 and 24 hours gave statistically indistinguishable
non-ischemic values, so they were pooled and considered as
a single group (N 5 15). Body temperature monitored in 3
rats at the end of 90 minutes of ischemia did not go below
37°C.
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Biochemical parameters
Ischemia and reperfusion resulted in a depletion of total
intracellular glutathione stores (from 14.3 6 1.33 to 8.20 6
0.56 and 9.01 6 0.51 mmol/g at 2 hrs of reperfusion for
controls and treated rats, respectively), that was associated
with a significant increment of glutathione redox balance
(oxidized vs. total glutathione %) both in treated and
control rats (Fig. 1A). In animals treated with lazaroid,
both after 2 and 24 hours of reperfusion, the alteration of
glutathione redox ratio was significantly reduced.
After 24 hours of reperfusion, intracellular ATP stores
showed a trend to regain baseline values both in treated
and control rats. However, while U83836E caused an
almost complete recovery to pre-ischemic conditions, these
levels were still significantly depleted in control animals,
indicating a lower metabolic rate (Fig. 1B). Total adenine
nucleotide levels (TAN, which is the sum of ATP, ADP and
AMP) followed the ATP behavior, being higher in treated
animals both after 2 and 24 hours of reperfusion (7.36 6 0.9
vs. 6.56 6 1.0 and 14.18 6 6.5 vs. 9.74 6 3.4 mmol/g, 2 and
24 hr, treated vs. control). After 24 hours, the recovery to
the pre-ischemic value (15.7 6 1.9 mmol/g) was complete in
treated animals, while it was still in progress in controls
(P , 0.05 vs. basal value). In a previous set of experiments
on U74389F efficacy [9], we observed that the ATP/ADP
ratio lowers significantly immediately after a 90-minute
ischemic period (0.69 6 0.18 vs. 1.39 6 0.27 in the sham
operated). In the present experiments a trend to a quicker
recovery could be recognized after 24 hours in the treated
group (0.83 6 0.8 vs. 0.78 6 0.6 mmol/g in the controls), but
it was not significant.
Diene conjugates and fluorescent Schiff bases increased
notably during reperfusion (P , 0.05 vs. baseline), and
remained high after 24 hours in both control and treated
animals (Fig. 2). U83836E, however, proved quite effective
in reducing the extension of lipid peroxidation both at 2
and 24 hours of reperfusion (P , 0.05 vs. controls).
Renal function
Plasma creatinine levels and BUN before ischemia and
after 2 and 24 hours of reperfusion are shown in Table 1. As
expected, no difference vs. basal value or between treat-
ments was observed after two hours of reperfusion. The
beneficial effect of U83836E was clearly shown after 24
hours of reperfusion, when the increment in plasma creat-
inine and BUN was much more evident in the control
group (P , 0.05 vs. treated group).
Renal morphology
The histologic features assessed in rat kidneys as de-
scribed in the Methods section are reported in Table 2.
After two hours of reperfusion, the control group showed
kidney necrosis that was not significantly different from the
U83836E group, with detectable renal abnormalities lim-
ited to mild interstitial edema, with few scattered foci of
hemorrhage. Only the presence of tubular casts differed
significantly in the control group versus the U83836E
treated group (P , 0.01 vs. treated). Histological analysis
after 24 hours of reperfusion (Fig. 3) showed that necrosis
of individual tubular epithelial cells and the presence of
tubular casts were the most severe alterations in controls,
with large and irregular confluent areas of parenchymal
hemorrhage and necrosis, tubular dilation, vacuolization
and thrombosis of blood vessels. Conversely, histological
examination of the kidneys of treated animals revealed
focal and small hyperemic and necrotic areas (P , 0.03
treated vs. controls) with dilated tubules and a background
of mildly interstitial inflammatory cells. Moreover, with
regards to the non-necrotic response, the U83836E showed
Fig. 1. Effects of U83836E after 90 minutes renal ischemia plus 2 or 24
hours reperfusion. (A) Glutathione redox ratio (free oxidized to total free,
ratio %). (B) ATP. Kidneys were treated as described in the Methods
section. Values are means 6 SE. Symbols are: (M) sham-operated animals;
(f) control groups; (o) treated groups. *P , 0.05 versus control group.
§P , 0.05 vs. sham-operated value.
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a lack of significant change when compared to the sham
group.
DISCUSSION
Ischemia-reperfusion injury sustained by kidney during
surgical revascularization of the renal artery or after trans-
plantation often results in temporary or permanent alter-
ations of renal function [22, 23]. During ischemia and
reperfusion, a massive production of oxygen free radicals
associated with an impairment of the antioxidant system
triggers lipid peroxidation by removing hydrogen atoms
from polyunsaturated fatty acids, thus leading to tissue
injury [24–26]. In the last years, several studies have found
that high doses of steroids can inhibit lipid peroxidation [1].
This observation led to the development of the so-called
“lazaroids” (21-aminosteroids), which are characterized by
a steroid structure and absence of glucocorticoid activity.
Among these compounds, U74006F, known as Tirilazad
mesylate, has been employed in the treatment of subarach-
noid hemorrhage in a multicenter clinical trial [27]. The
antioxidant capacity of the 2-methylaminochroman, U78517F,
a second generation lazaroid, has been reported to be
tenfold that of the 21-aminosteroid U74006F and 100-fold
that of vitamin E, probably because the association of the
antioxidant properties of vitamin E with the amino portion
of U74006F enhances drug antioxidant potency and effi-
cacy [13].
In our previous experiments on U74389F (structurally
similar to U74006F) at 2 mg/kg, in a mild model of acute
renal failure (60 min ischemia) evidenced some drug
efficacy only after two hours reperfusion, while after 24
hours most of the tested biochemical parameters also
returned to baseline values in untreated animals. A longer
clamp period (90 min) was therefore necessary to establish
the drug’s effect on the glutathione redox ratio at 24 hours
of reperfusion. Nevertheless, U74389F failed to protect
against lipid peroxidation and ATP depletion.
Based on these results, the protection of the 2-methyl-
aminochroman U83836E (enantiomer of U78517F) at 3
mg/kg was tested using a 90-minute clamp time. The results
are suggestive of a stronger efficacy, and consistent with an
additive or synergistic effect of the chromanol moiety
together with the amino functionality of U74389F. The
2-methylaminochromans as well as the 21-aminosteroids
exert their effects via several mechanisms such as scaveng-
ing of peroxyl radicals [11], inactivation of iron-mediated
toxic reactions by interaction with ferrous iron [2], and the
blocking of calcium channels by inhibition of ion pump
ATPase [18]. The long lasting protection from lipid peroxi-
dation and from nucleotide depletion in the kidney by
U83836E even after 24 hours of reperfusion can also be
ascribed to a longer metabolic half-life in comparison with
the relatively short one of the old generation of 21-
aminosteroids (U34389F) [11]. In consequence, it could be
speculated that there is a different bioavailability because
of the higher solubility of U83836E at physiological pH
than U74389F. This could lead to a more efficient O2
z and
OHz scavenging ability of U83836E to inhibit toxic reac-
tions in the aqueous cell environment.
It is well known that ATP levels fall within a few seconds
of ischemia (,1 mmol/g wet wt). Therefore, despite the
rapid time course between the removal of the kidney from
the animal and subsequent freezing in liquid nitrogen, this
degradation is to be kept in mind when analyzing the
validity of present study’s methods. Nevertheless, our ex-
perimental model clearly showed the protective action of
the tested lazaroid versus controls, as it well supported the
restoration of kidney ATP pool together with the other
Fig. 2. Effects of U83836E after 90 minutes renal ischemia plus 2 or 24
hours reperfusion. (A) Diene conjugates. (B) Fluorescent products.
Kidneys were treated as described under Methods. Values are means 6
SE. Abbreviations are: U.A., units of absorbance; U.F., units of fluores-
cence. Symbols are: (M) sham-operated animals; (f) controls groups; (o)
treated groups. *P , 0.05 vs. control group. §P , 0.05 vs. sham-operated
value.
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adenine nucleotides depleted during the ischemic period,
with an almost complete recovery to baseline values after
24 hours of reperfusion.
The degree of renal function protection by U83836E was
also confirmed by the significant differences found in
plasma creatinine after 24 hours of reperfusion, a beneficial
effect that was not evidenced with U74389F [10]. A similar
result on renal function was obtained by Stanley et al in
1993, who employed a rather high dosage of U74006F (10
mg/kg21), while at a lower dosage (3 mg/kg) no notable
effects were observed [8]. Although the possible influence
of U83836E on the glomerular filtration rate of the kidney
was not directly assessed, the efficacy of U83836E is clearly
evidenced by plasma creatinine, which is also the main
parameter used to evaluate renal function in clinical prac-
tice.
In the present study the tissue’s histological appearance
was also examined. As well as for renal function, histolog-
ical examination did not reveal marked differences between
treated and control rats after two hours of reperfusion,
which appears to be too short a period to evidence such
alterations. Morphological damage induced by prolonged
ischemia was well established after 24 hours reperfusion
and clearly counteracted by U83836E administration, as
was already reported in a similar animal model of kidney
ischemia-reperfusion injury with U74006F [8]. The amelio-
ration of microvascular thromboses documented at two
hours and more extensively at 24 hours in control kidneys
Table 1. Baseline and post-ischemic creatinine and blood urea nitrogen (BUN) levels
Reperfusion
period
Creatinine mg/dl BUN mg/dl
Controls Treated Controls Treated
2 hours (N 5 8) 0.37 6 0.06 0.43 6 0.04 57 6 3.9 52 6 2.33
24 hours (N 5 6) 1.95 6 0.13a 1.13 6 0.27ab 71.7 6 8.2 47.4 6 3.5b
Data are expressed as mean 6 SE. The number of animals for each experimental group is given in parentheses. Pre-ischemic values determined in
15 sham-operated rats were 0.44 6 0.03 mg/dl for creatinine and 48 6 2.3 mg/dl for BUN.
a P , 0.05 vs. baseline value
b P , 0.05 vs. control group
Table 2. Grading of lesions in controls and treated rat kidneys
Reperfusion
time
Neutrophils in
vasa recta
Tubular
necrosis
Tubular
regeneration
Tubular cell
mitoses
Interstitial
inflammation
Tubular
casts
Brush
border loss
2 Hours
C1 0 1 1 0 0 2 2
C2 0 2 1 0 0 2 2
C3 0 1 0 0 1 1 2
C4 0 2 1 0 0 2 2
C5 0 2 1 0 1 2 2
C6 0 2 1 0 1 2 2
C7 0 1 1 0 1 2 2
C8 0 2 1 0 1 2 2
T1 0 1 0 0 0 1 2
T2 0 1 1 0 0 1 2
T3 0 2 1 0 1 2 2
T4 0 1 1 0 0 1 2
T5 0 1 1 0 0 1 2
T6 0 2 1 0 0 1 2
T7 0 1 1 0 1 1 2
T8 0 1 2 0 0 1 2
24 Hours
C1 0 2 2 0 0 3 2
C2 0 3 1 0 1 2 2
C3 0 2 2 0 1 2 2
C4 0 2 2 0 0 3 2
C5 0 3 3 0 1 3 2
C6 0 3 1 0 1 2 2
T1 0 2 1 0 0 2 2
T2 0 1 1 0 1 1 2
T3 0 1 1 0 0 3 2
T4 0 2 2 0 0 2 2
T5 0 2 1 0 1 1 2
T6 0 1 1 0 1 1 2
Scores are defined as: 0 5 negative; 1 5 ,20%; 2 5 20–50%; 3 5 .50% of tissue area morphologic changes. Abbreviations are: C, controls; T,
treated.
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can be explained by the possible anticoagulant effect of
U83836E. Although to our knowledge no data on this issue
exist, this possibility cannot be completely excluded.
In conclusion, our data confirm the validity of lazaroid
treatment against ischemia-reperfusion injury in a rat
model of severe ischemia (90 min). The protection of
U83836E against a milder model of acute renal failure (60
min clamp), under strictly regulated normothermic condi-
tions, which is perhaps physiologically more relevant, can
also be hypothesized, although it was not experimentally
tested in this protocol. Employing 2-methylchromans for
the prevention of renal ischemia-reperfusion injury in
humans merits further investigation.
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Fig. 3. Histological appearance of a cortical
field of a rat kidney sacrificed 24 hours after 90
minutes ischemia. (A) Control kidney. (B)
U83836E treated kidney. In the control group,
kidney tubular cell necrosis (presence of
necrotic cells or denuded areas of tubular
basement membrane; arrows) is less discrete
and less focally distributed than in the treated
animals (hematoxylin and eosin, 325).
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APPENDIX
Abbreviations used in this article are: ADP, adenosine
59-diphosphate; AMP, adenosine monophosphate; ANOVA,
analysis of variance; ATP, adenosine triphosphate; BUN,
blood urea nitrogen; HPLC, high performance liquid chro-
matography; PAS, periodic acid Schiff; PBS, phosphate
buffered saline; TAN, total adenine nucleotide.
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